Adrenocortical functioning in boys with attention-deficit/hyperactivity disorder: examining subtypes of ADHD and associated comorbid conditions.
Disruptions to hypothalamic-pituitary-adrenal (HPA) axis function have been associated with varying forms of psychopathology in children. Studies suggesting children with ADHD have blunted HPA function have been complicated by the prevalence of comorbid diagnoses and heterogeneity of ADHD. The goals of this research were to assess the relations between waking and stress-response salivary cortisol levels and comorbid disruptive behavior (DBD) and anxiety (AnxD) disorders and problems in boys with ADHD, and to examine whether cortisol levels varied across ADHD subtypes. One hundred seventy elementary school-age boys with ADHD provided salivary cortisol at waking and in reaction to venipuncture. Parent reports were used to assess boys' psychiatric diagnoses and severity of behavioral problems. Boys' comorbid AnxD and anxiety problems were associated with greater cortisol reactivity, whereas boys' comorbid DBD and oppositional problems predicted diminished adrenocortical activity. Reactive cortisol increases were greatest in boys with ADHD and comorbid AnxD, but without DBD. ADHD subtypes were not differentially associated with waking, pre-stress baseline, or reactive cortisol levels. However, comorbid DBD predicted decreased cortisol reactivity in boys with inattentive and hyperactive subtypes of ADHD, but not in boys with combined subtype of ADHD. The results clarify previous patterns of distinct and divergent dysregulations of HPA function associated with boys' varying kinds of psychopathology.
Hastings
Paul D
PD
Department of Psychology, Centre for Research in Human Development, Concordia University, QC, Canada. Paul.Hastings@Concordia.ca
Fortier
Isabel
I
Utendale
William T
WT
Simard
Louise R
LR
Robaey
Philippe
P
D001008:Anxiety Disorders / Q000453:epidemiology / Q000378:metabolism* / Q000523:psychology; D001289:Attention Deficit Disorder with Hyperactivity / Q000145:classification / Q000453:epidemiology / Q000378:metabolism* / Q000523:psychology; D002170:Canada / Q000453:epidemiology; D002648:Child; D015897:Comorbidity; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D008297:Male; D018962:Phlebotomy / Q000523:psychology; D010913:Pituitary-Adrenal System / Q000378:metabolism* / Q000503:physiopathology; D011569:Psychiatric Status Rating Scales; D012463:Saliva / Q000378:metabolism; D013315:Stress, Psychological / Q000150:complications / Q000378:metabolism*; D014851:Wakefulness
D006854:Hydrocortisone